Protective effect of chronic vitamin C treatment on endothelial function of apolipoprotein E-deficient mouse carotid artery

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 1, 2003, Pages 103-108

  Matsumoto, Takuya ^a   D'Uscio, Livius V ^a   Eguchi, Daihiko ^a   Akiyama, Masahiko ^a   Smith, Leslie A ^a   Katusic, Zvonimir S ^a  

^a DEPARTMENT OF UROLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; APOLIPOPROTEIN E; ASCORBIC ACID; CD31 ANTIGEN; CYCLIC GMP; DIETHYLAMMONIUM 1 (N,N DIETHYLAMINO)DIAZENIUM 1,2 DIOLATE; ISOBUTYLMETHYLXANTHINE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOAVAILABILITY; BLOOD VESSEL REACTIVITY; CARDIOVASCULAR DISEASE; CAROTID ARTERY; CELL FUNCTION; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENDOTHELIUM LESION; ENZYME INACTIVATION; FAT INTAKE; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LONG TERM CARE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOIMMUNOASSAY; VASOMOTOR REFLEX; VITAMIN INTAKE;

ANIMALS; ANTIGENS, CD31; ANTIOXIDANTS; APOLIPOPROTEINS E; ASCORBIC ACID; BODY WEIGHT; CAROTID ARTERIES; CHOLESTEROL; CYCLIC AMP; CYCLIC GMP; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III;

EID: 0038003032     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.049163     Document Type: Article

References (34)

1. Baker TA, Milstien S, and Katusic ZS (2001) Effect of vitamin C on the availability of tetrahydrobiopterin in human endothelial cells. J Cardiovasc Pharmacol 37:333-338.
2. Bhattacharjee J, Chakraborty AS, Sarkar NK, Basu A, and Mitra S (1985) Study of ascorbate status in murine and human leukaemias. J Comp Pathol 95:87-91.
3. Buzello M, Tornig J, Faulhaber J, Ehmke H, Ritz E, and Amann K (2003) The apolipoprotein E knockout mouse: a model documenting accelerated atherogenesis in uremia. J Am Soc Nephrol 14:311-316.
4. Cai H and Harrison DG (2000) Endothelial dysfunction in cardiovascular diseases. The role of oxidant stress. Circ Res 87:840-844.
5. Chen ZJ, Che D, and Chang CH (2001) Antioxidants, vitamin C and dithiothreitol, activate membrane-bound guanylate cyclase in PC 12 cells. J Pharm Pharmacol 53:243-247.
6. 2-metabolism by catalase. Free Radic Biol Med 7:485-490.
7. Cosentino F and Katusic ZS (1995) Tetrahydrobiopterin and dysfunction of endothelial nitric oxide synthase in coronary arteries. Circulation 91:139-144.
8. Davies MJ, Gordon JL, Gearing AJ, Pigott R, Woolf N, Katz D, and Kyriakopoulous A (1993) The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM and E-selectin in human atherosclerosis. J Pathol 171:223-229.
9. d'Uscio LV, Milstien S, Richardson D, Smith L, Katusic ZS (2003) Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity. Circ Res 92:88-95.
10. d'Uscio LV, Smith L, and Katusic ZS (2001) Hypercholesterolemia impairs endothelium-dependent relaxations in common carotid arteries of apolipoprotein E-deficient mice. Stroke 32:2658-2664.
11. Heller R, Munscher Paulig F, Grabner R, and Till U (1999) L-Ascorbic acid potentiates nitric oxide synthesis in endothelial cells. J Biol Chem 274:8254-8260.
12. Heller R, Unbehaun A, Schellenberg B, Mayer B, Werner-Felmayer G, and Werner ER (2001) L-Ascorbic acid potentiates endothelial nitric oxide synthesis via a chemical stabilization of tetrahydrobiopterin. J Biol Chem 276:40-47.
13. Huang A, Vita JA, Venema RC, and Keaney JF Jr (2000) Ascorbic acid enhances endothelial nitric-oxide synthase activity by increasing intracellular tetrahydrobiopterin. J Biol Chem 275:17399-17406.
14. Jackson TS, Xu A, Vita JA, and Keaney JF Jr (1998) Ascorbate prevents the interaction of superoxide and nitric oxide only at very high physiological concentrations. Circ Res 83:916-922.
15. Kritchevsky SB, Shimakawa T, Tell GS, Dennis B, Carpenter M, Eckfeldt JH, Peacher-Ryan H, and Heiss G (1995) Dietary antioxidants and carotid artery wall thickness. The ARIC Study. Atherosclerosis Risk in Communities Study. Circulation 92:2142-2150.
16. Kurl S, Tuomainen TP, Laukkanen JA, Nyyssonen K, Lakka T, Sivenius J, and Salonen JT (2002) Plasma vitamin C modifies the association between hypertension and risk of stroke. Stroke 33:1568-1573.
17. Lehr H, Frei B, and Arfors K (1994) Vitamin C prevents cigarette smoke-induced leukocyte aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA 91:7688-7692.
18. Lehr H, Frei B, Olofsson AM, Carew TE, and Arfors KE (1995) Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E. Circulation 91:1525-1532.
19. Levine M, Rumsey SC, Daruwala R, Park JB, and Wang Y (1999) Criteria and recommendations for vitamin C intake. J Am Med Assoc 281:1415-1423.
20. Lincoln TM, Dey N, and Sellak H (2001) cGMP-dependent protein kinase signaling mechanisms in smooth muscle: from the regulation of tone to gene expression. J Appl Physiol 91:1421-1430.
21. Molina CR, Andresen JW, Rapoport RM, Waldman S, and Murad F (1987) Effect of in vivo nitroglycerin therapy on endothelium-dependent and independent vascular relaxation and cyclic GMP accumulation in rat aorta. J Cardiovasc Pharmacol 10:371-378.
22. Muldoon MF, Kritchevsky SB, Evans RW, and Kagan VE (1996) Serum total antioxidant activity in relative hypo- and hypercholesterolemia. Free Radic Res 25:239-245.
23. O'Brien KD, McDonald TO, Chait A, Allen MD, Alpers CE (1996) Neovascular expression of E-selectin, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in human atherosclerosis and their relation to intimal leukocyte content. Circulation 93:672-682.
24. Ohashi Y, Kawashima S, Hirata K, Yamashita T, Ishida T, Inoue N, Sakoda T, Kurihara H, Yazaki Y, and Yokoyama M (1998) Hypotension and reduced nitric oxide-elicited vasorelaxation in transgenic mice overexpressing endothelial nitric oxide synthase. J Clin Investig 102:2061-2071.
25. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, and Breslow JL (1992) Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell 71:343-353.
26. Poston RN and Johnson-Tidey RR (1996) Localized adhesion of monocytes to human atherosclerotic plaques demonstrated in vitro: implications for atherogenesis. Am J Pathol 149:73-80.
27. Rang HP, Dale MM, Ritter JM, and Gardner P (2001) The vascular system, in Pharmacology, 4th ed, pp 278-300, Churchill Livingstone, London.
28. Schrammel A, Koesling D, Schmidt K, and Mayer D (2000) Inhibition of purified soluble guanylyl cyclase by L-ascorbic acid. Cardiovasc Res 47:602-608.
29. Simon JA, Hudes ES, and Browner WS (1998) Serum ascorbic acid and cardiovascular disease prevalence in US adults. Epidemiology 9:316-321.
30. Vaporciyan AA, DeLisser HM, Yan HC, Mendiguren II, Thom SR, Jones ML, Ward PA, and Albelda SM (1993) Involvement of platelet-endothelial cell adhesion molecule-1 in neutrophil recruitment in vivo. Science (Wash DC) 262:1580-1582.
31. Weber C, Erl W, Weber K, and Weber PC (1996) Increased adhesiveness of isolated monocytes to endothelium is prevented by vitamin C intake in smokers. Circulation 93:1488-1492.
32. Yang R, Powell-Braxton L, Ogaoawara AK, Dybdal N, Bunting S, Ohneda O, and Jin H (1999) Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. Arterioscler Thromb Vasc Biol 19:2762-2768.
33. Zeiher AM, Drexler H, Wollshlager H, and Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391-401.
34. Zhang SH, Reddick RL, Piedrahita JA, and Maeda N (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science (Wash DC) 255:468-471.